Archive: 29/08/2016

Shorter dual antiplatelet duration holds up in NIPPON

A short-term course of dual antiplatelet therapy (DAPT) is non-inferior to a longer course in patients who have undergone placement of a particular kind of drug-eluting stent (DES), researchers reported here.

SAVE - sleep apnea treatment: No cardiovascular benefit

More than 3 years of nightly treatment with a continuous positive airway pressure (CPAP) machine did not reduce cardiovascular risk more than usual care among patients with cardiovascular disease and obstructive sleep apnea ...

How a particular gene protects against psoriasis

There is currently no cure for the skin disease psoriasis. However, in a new study conducted at Karolinska Institutet and published in the Journal of Allergy and Clinical Immunology, scientists show that the miR-146a gene ...

page 6 from 9